Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
CrossRef Evolution of Research on Cell-Specific Magnetic Resonance Imaging Contrast Agents in Hepatocellular Carcinoma: A Bibliometric Study ChenWei Zhang, TianAi Zhang, ShaoZhong Ni Hepatitis Monthly .2026;[Epub] CrossRef The LINC02041/SRSF1 Axis Facilitates Aerobic Glycolysis and Stemness Maintenance in Hepatocellular Carcinoma Mingjiao Cheng, Anqi Cheng, Chenglong Li, Zhibiao Zhang, Tingjiang He, Ludan Zhang, Qianwei Zhao, Jingjing Liu, Weiwei Lin, Jintao Zhang, Fang Xu Cells .2026
A long-acting release form of exenatide (exenatide ER, Bydureon) was approved by the FDA in 2012, becoming the first once-weekly injection of a GLP-1RA for adults with T2DM [ Table 2 ]
6 , e2324465 (2023)
In reality, up to 70% of patients stop GLP-1 treatment within a year most often due to: High cost (GLP-1s can cost $1,000+ per month without insurance) Loss of insurance coverage for weight loss treatment Side effects such as nausea, diarrhea, constipation, or fatigue A Misconceptions some patients stop once they lose initial weight, believing they no longer need the medication 2
Get enough sleep One small study found that people with insomnia had significantly lower levels of glutathione peroxidase (11)
US$ 26.18
US$ 21.12
US$ 23.04
US$ 27.02
US$ 21.83
US$ 25.92
